Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline.
(2007) In Neurobiology of Disease 25. p.198-205- Abstract
- Minocycline has been shown to be neuroprotective in ischemic and neurodegenerative disease models and could potentially be relevant for clinical use. We revisited the hypothesis that minocycline acts through direct inhibition of calcium-induced mitochondrial permeability transition (mPT) resulting in reduced release of cytochrome c (cyt c). Minocycline, at high dosage, was found to prevent calcium-induced mitochondrial swelling under energized conditions similarly to the mPT inhibitor cyclosporin A (CsA) in rodent mitochondria derived from the CNS. In contrast to CsA, minocycline dose-dependently reduced mitochondrial calcium retention capacity (CRC) and respiratory control ratios and was ineffective in the de-energized mPT assay. Further,... (More)
- Minocycline has been shown to be neuroprotective in ischemic and neurodegenerative disease models and could potentially be relevant for clinical use. We revisited the hypothesis that minocycline acts through direct inhibition of calcium-induced mitochondrial permeability transition (mPT) resulting in reduced release of cytochrome c (cyt c). Minocycline, at high dosage, was found to prevent calcium-induced mitochondrial swelling under energized conditions similarly to the mPT inhibitor cyclosporin A (CsA) in rodent mitochondria derived from the CNS. In contrast to CsA, minocycline dose-dependently reduced mitochondrial calcium retention capacity (CRC) and respiratory control ratios and was ineffective in the de-energized mPT assay. Further, minocycline did not inhibit calcium- or tBid-induced cyt c release. We conclude that the neuroprotective mechanism of minocycline is likely not related to direct inhibition of mPT and propose that the mitochondrial effects of minocycline may contribute to toxicity rather than tissue protection at high dosing in animals and humans. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/162110
- author
- Månsson, Roland
LU
; Hansson, Magnus
LU
; Morota, Saori ; Uchino, Hiroyuki ; Ekdahl Clementson, Christine LU and Elmer, Eskil LU
- organization
- publishing date
- 2007
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Neurobiology of Disease
- volume
- 25
- pages
- 198 - 205
- publisher
- Academic Press
- external identifiers
-
- wos:000242665200021
- scopus:33751093803
- pmid:17067803
- ISSN
- 0969-9961
- DOI
- 10.1016/j.nbd.2006.09.008
- language
- English
- LU publication?
- yes
- id
- c3d35e14-773b-4d7e-92eb-41bb7d163fd5 (old id 162110)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17067803&dopt=Abstract
- date added to LUP
- 2016-04-01 11:54:14
- date last changed
- 2025-04-04 14:01:21
@article{c3d35e14-773b-4d7e-92eb-41bb7d163fd5, abstract = {{Minocycline has been shown to be neuroprotective in ischemic and neurodegenerative disease models and could potentially be relevant for clinical use. We revisited the hypothesis that minocycline acts through direct inhibition of calcium-induced mitochondrial permeability transition (mPT) resulting in reduced release of cytochrome c (cyt c). Minocycline, at high dosage, was found to prevent calcium-induced mitochondrial swelling under energized conditions similarly to the mPT inhibitor cyclosporin A (CsA) in rodent mitochondria derived from the CNS. In contrast to CsA, minocycline dose-dependently reduced mitochondrial calcium retention capacity (CRC) and respiratory control ratios and was ineffective in the de-energized mPT assay. Further, minocycline did not inhibit calcium- or tBid-induced cyt c release. We conclude that the neuroprotective mechanism of minocycline is likely not related to direct inhibition of mPT and propose that the mitochondrial effects of minocycline may contribute to toxicity rather than tissue protection at high dosing in animals and humans.}}, author = {{Månsson, Roland and Hansson, Magnus and Morota, Saori and Uchino, Hiroyuki and Ekdahl Clementson, Christine and Elmer, Eskil}}, issn = {{0969-9961}}, language = {{eng}}, pages = {{198--205}}, publisher = {{Academic Press}}, series = {{Neurobiology of Disease}}, title = {{Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline.}}, url = {{https://lup.lub.lu.se/search/files/2695080/625694.pdf}}, doi = {{10.1016/j.nbd.2006.09.008}}, volume = {{25}}, year = {{2007}}, }